Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disordersWORLD JOURNAL OF DIABETESIF4.62023-05-158OAAI
Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychosesworld psychiatryIF3.42023-04-191OAAI
Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of DepressivenessCELLSIF5.22023-02-233OAAI
Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs cautionFRONTIERS IN PSYCHIATRYIF3.22022-10-194OAAI
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognitionworld psychiatryIF3.42022-09-192OAAI
Galectin-3 Involvement in Cognitive Processes for New Therapeutic ConsiderationsFRONTIERS IN CELLULAR NEUROSCIENCEIF42022-07-0512OAAI
The Influence of Serum Uric Acid on the Brain and Cognitive DysfunctionFRONTIERS IN PSYCHIATRYIF3.22022-04-2246OAAI
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in SchizophreniaFRONTIERS IN PSYCHIATRYIF3.22022-02-149OAAI
Psychiatry trainees' attitudes, knowledge and training in addiction psychiatry - a European surveyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireviewWORLD JOURNAL OF DIABETESIF4.62021-10-154OAAI
Psychiatry Trainees' Attitudes, Knowledge, and Training in Addiction Psychiatry-A European SurveyFRONTIERS IN PSYCHIATRYIF3.22021-01-087OAAI
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 TreatmentFRONTIERS IN PSYCHIATRYIF3.22020-12-239OAAI
Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable SchizophreniaDIAGNOSTICSIF3.32020-11-1027OAAI
Cross-national trainee collaboration-The EFPT research experience in psychiatryEUROPEAN PSYCHIATRYIF6.72020-03-230PREAI
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in PsychosisFRONTIERS IN PSYCHIATRYIF3.22018-06-2231OAAI
Interleukin-6 in Schizophrenia - Is There a Therapeutic Relevance?FRONTIERS IN PSYCHIATRYIF3.22017-11-0664OAAI
Depression correlates with sexual dysfunction and fatigue in multiple sclerosis patientsJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22015-10-011OAAI